APA (7th ed.) Citation

TY, H., IC, C., TS, W., SM, L., CM, K., YJ, C., . . . YM, C. (2026). Candidate pharmacogenetic signals at CCL2 and ITPA associated with JAK inhibitor response in Taiwanese rheumatoid arthritis. Clinical and experimental rheumatology. https://doi.org/10.55563/clinexprheumatol/17yc25

Chicago Style (17th ed.) Citation

TY, Hsieh, Chen IC, Wu TS, Lo SM, Kao CM, Chen YJ, Huang WN, Liu FC, and Chen YM. "Candidate Pharmacogenetic Signals at CCL2 and ITPA Associated with JAK Inhibitor Response in Taiwanese Rheumatoid Arthritis." Clinical and Experimental Rheumatology 2026. https://doi.org/10.55563/clinexprheumatol/17yc25.

MLA (9th ed.) Citation

TY, Hsieh, et al. "Candidate Pharmacogenetic Signals at CCL2 and ITPA Associated with JAK Inhibitor Response in Taiwanese Rheumatoid Arthritis." Clinical and Experimental Rheumatology, 2026, https://doi.org/10.55563/clinexprheumatol/17yc25.